Global Cord Blood (NYSE:CO) Now Covered by Analysts at StockNews.com

StockNews.com started coverage on shares of Global Cord Blood (NYSE:COFree Report) in a report released on Saturday. The brokerage issued a strong-buy rating on the medical research company’s stock.

Global Cord Blood Price Performance

Global Cord Blood stock opened at $1.75 on Friday. The firm has a 50-day moving average of $1.58 and a 200-day moving average of $1.36. The company has a market cap of $212.71 million, a price-to-earnings ratio of 2.73 and a beta of 0.16. Global Cord Blood has a one year low of $2.03 and a one year high of $5.50.

Global Cord Blood Company Profile

(Get Free Report)

Global Cord Blood operates as a holding company, which engages in the provision of cord blood banking services. It provides cord blood processing and storage service. The company also offers cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services. The firm preserves cord blood units donated by the public and provides matching services on such donated units and deliver matching units to patients in need of transplants.

Featured Stories

Receive News & Ratings for Global Cord Blood Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Global Cord Blood and related companies with MarketBeat.com's FREE daily email newsletter.